The estimated Net Worth of Michael D Pruitt is at least $8.9 Tisíc dollars as of 20 December 2023. Michael Pruitt owns over 3,333 units of IMAC Inc stock worth over $8,896 and over the last 9 years Michael sold IMAC stock worth over $0.
Michael has made over 37 trades of the IMAC Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Michael exercised 3,333 units of IMAC stock worth $3,366 on 20 December 2023.
The largest trade Michael's ever made was exercising 50,000 units of IMAC Inc stock on 1 January 2022 worth over $50,500. On average, Michael trades about 3,374 units every 66 days since 2016. As of 20 December 2023 Michael still owns at least 8,808 units of IMAC Inc stock.
You can see the complete history of Michael Pruitt stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD, TN, 37027.
Over the last 6 years, insiders at IMAC Inc have traded over $640,000 worth of IMAC Inc stock and bought 19,852 units worth $9,124 . The most active insiders traders include Cary Sucoff, Matthew C Wallis a Gerard M Jr Hayden. On average, IMAC Inc executives and independent directors trade stock every 48 days with the average trade being worth of $25,399. The most recent stock trade was executed by Cary Sucoff on 20 December 2023, trading 3,333 units of IMAC stock currently worth $3,366.
IMAC was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life-science advancements with traditional medical care for movement restricting diseases and conditions. IMAC owns or manages more than 15 outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has partnered with several active and former professional athletes including Ozzie Smith, David Price, Mike Ditka and Tony Delk. IMAC’s outpatient medical clinics emphasize treating sports and orthopedic injuries and movement-restricting diseases without surgery or opioids.
IMAC Inc executives and other stock owners filed with the SEC include: